98 related articles for article (PubMed ID: 17515332)
21. Control and stability of drug release from diffusion pellets coated with the aqueous quaternary polymethacrylate dispersion Eudragit RS 30 D.
Lippold BC; Monells Pagés R
Pharmazie; 2001 Jun; 56(6):477-83. PubMed ID: 11446169
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
[TBL] [Abstract][Full Text] [Related]
23. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
Cui Y; Zhang Y; Tang X
Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
[TBL] [Abstract][Full Text] [Related]
25. Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium.
Munday DL
Drug Dev Ind Pharm; 2003 May; 29(5):575-83. PubMed ID: 12779287
[TBL] [Abstract][Full Text] [Related]
26. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
27. Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
Kucera SA; McGinity JW; Zheng W; Shah NH; Malick AW; Infeld MH
Drug Dev Ind Pharm; 2007 Jul; 33(7):717-26. PubMed ID: 17654020
[TBL] [Abstract][Full Text] [Related]
28. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Zheng W; McGinity JW
Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
[TBL] [Abstract][Full Text] [Related]
29. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
[TBL] [Abstract][Full Text] [Related]
30. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
Ensslin S; Moll KP; Metz H; Otz M; Mäder K
Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
[TBL] [Abstract][Full Text] [Related]
31. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
[TBL] [Abstract][Full Text] [Related]
32. In vitro study on sustained release capsule formulation of acetazolamide.
Pandey VP; Kannan K; Manavalan R; Desai N
Boll Chim Farm; 2003 Oct; 142(8):357-60. PubMed ID: 15040467
[TBL] [Abstract][Full Text] [Related]
33. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
34. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
[TBL] [Abstract][Full Text] [Related]
35. Influence of fumed silicon dioxide on the stabilization of Eudragit RS/RL 30 D film-coated theophylline pellets.
Kucera SA; Stimpel D; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2008; 13(3):245-53. PubMed ID: 18484493
[TBL] [Abstract][Full Text] [Related]
36. [Drug release mechanism of famotidine time-controlled release pellets].
Zhang L; Chen DW; Gao ZB
Yao Xue Xue Bao; 2006 Sep; 41(9):873-7. PubMed ID: 17111836
[TBL] [Abstract][Full Text] [Related]
37. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
[TBL] [Abstract][Full Text] [Related]
38. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
39. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
Sriamornsak P; Kennedy RA
Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.
Kállai N; Luhn O; Dredán J; Kovács K; Lengyel M; Antal I
AAPS PharmSciTech; 2010 Mar; 11(1):383-91. PubMed ID: 20237965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
